Literature DB >> 2024498

Characterization of human immunodeficiency virus type 1 strains recovered from the bowel of infected individuals.

S W Barnett1, A Barboza, C M Wilcox, C E Forsmark, J A Levy.   

Abstract

HIV-1 isolates were recovered from biopsy tissues from the small bowel, colon, and rectum of 10 infected individuals with severe diarrhea. In general, the bowel strains grew well in primary macrophage and lymphocyte cultures, not in T or B cell lines. They induced cytopathic effects such as syncytia formation and cell killing in peripheral blood mononuclear cells and were usually sensitive to serum neutralization. Several of these isolates were able to infect bowel epithelial cell lines, but this characteristic was also observed with blood-derived strains. Differences could be identified in 3 of 6 cases of paired bowel and blood isolates from the same individual. When compared to blood-derived isolates, the bowel strains exhibited a relative inability to grow in established cell lines, a reduced ability to induce cytopathology in infected cells, and a greater sensitivity to serum neutralization. Thus, although distinct characteristics of bowel-derived HIV-1 strains were not found, certain biological and serological properties might differentiate these viruses from those isolated from other tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024498     DOI: 10.1016/0042-6822(91)90621-h

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

Review 1.  Potential therapeutics of vitamin E (tocopherol) in AIDS and HIV.

Authors:  Y Wang; R R Watson
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

2.  Founder virus population related to route of virus transmission: a determinant of intrahost human immunodeficiency virus type 1 evolution?

Authors:  V V Lukashov; J Goudsmit
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.

Authors:  M T Dittmar; G Simmons; Y Donaldson; P Simmonds; P R Clapham; T F Schulz; R A Weiss
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Correlation between CD4 T cell counts and virus compartmentalization in genital and systemic compartments of HIV-infected females.

Authors:  Suman Chaudhary; Richard J Noel; Nayra Rodríguez; Santiago Collado; Jhoanne Munoz; Anil Kumar; Yashuhiro Yamamura
Journal:  Virology       Date:  2011-07-13       Impact factor: 3.616

5.  Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1.

Authors:  M Poss; H L Martin; J K Kreiss; L Granville; B Chohan; P Nyange; K Mandaliya; J Overbaugh
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

6.  Isolation of human immunodeficiency virus type 1 (HIV-1) RNA from feces by a simple method and difference between HIV-1 subpopulations in feces and serum.

Authors:  L van der Hoek; R Boom; J Goudsmit; F Snijders; C J Sol
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1.

Authors:  S Y Chan; R F Speck; C Power; S L Gaffen; B Chesebro; M A Goldsmith
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor.

Authors:  J Fantini; D G Cook; N Nathanson; S L Spitalnik; F Gonzalez-Scarano
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets.

Authors:  A M Beebe; N Dua; T G Faith; P F Moore; N C Pedersen; S Dandekar
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.